Table 2. Clinical symptoms, evaluation, and diagnosis of monitored travelers requiring Clinical Ebola Team—Minnesota, October 21, 2014–May 15, 2015.

Signs and Symptoms	N = 43
Any symptom consistent with Ebola disease	29 (67%)
Temperature ≥100.4 F, or subjective fever	20 (47%)
Abdominal pain	12 (28%)
Cough, sore throat, and/or rhinorrhea	8 (19%)
Headache	6 (14%)
Myalgias	4 (9%)
Diarrhea	4 (9%)
Vomiting	3 (7%)
Unexpected bleeding	3 (7%)
Additional signs or symptoms*	15 (35%)
Ebola PCR performed	2 (5%)
Diagnoses by days from arrival to symptom onset¶
Symptom onset prior to travel but condition not diagnosed until after arrival (n = 16)	Fibroids, bone mass, abdominal tumor, irritable bowel syndrome, dementia, developmental delay, atrial fibrillation, orthopedic fracture, pregnancy/labor, tubo-ovarian abscess, urinary outflow tract obstruction
≤7days (n = 9)	Upper respiratory tract infection, malaria, congestive heart failure, menstrual cramps, enterovirus, gastroenteritis, asthma exacerbation, atrial fibrillation, Gram-negative prostatitis
8–14 days (n = 11)	Upper respiratory tract infection, probable norovirus, panic attack, pre-term labor, epistaxis, respiratory syncytial virus
15–21 days (n = 7)	Upper respiratory tract infection, pre-term labor, probable norovirus
Highest level of care delivered	N = 43
Ebola Clinical Team via telephone/video call	15 (35%)
Outpatient clinical evaluation (including ED)	15 (35%)
Hospitalized	13 (30%)

* Additional signs and symptoms may have accompanied other signs or symptoms and included: hypertension (3), shortness of breath (2), elevated liver enzymes (2), nausea (1), thrombocytopenia (1), dehydration (1), bone pain (1), confusion (1), developmental delay (1), lower extremity edema (1), and chest pain (1).

^¶ Ill travelers might have had multiple diagnoses.